CVS Health price target raised to $77 from $68 at Argus
Argus raised the firm’s price target on CVS Health (CVS) to $77 from $68 and keeps a Buy rating on the shares. Despite an uneven performance ...
Argus Research Sticks to Its Buy Rating for CVS Health (CVS)
In a report released on February 14, Steven Silver from Argus Research maintained a Buy rating on CVS Health (CVS – Research Report). The ...